(CIR) is a leader in vaccine evaluation and Good Clinical Practice (GCP) training. Established in 1985 by Dr. Mary Lou Clements-Mann, the CIR is one of the nation’s leading vaccine research centers. CIR investigators primarily conduct Phase I and II clinical trials of new vaccine candidates in the U.S. and in less-developed countries. The CIR has also achieved international recognition for its capacity to train other research professionals to develop the skills and infrastructure needed to design and conduct clinical vaccine trials, with a focus on applied GCP. The experienced personnel and facilities of the CIR serve as major resources for vaccine research at the Johns Hopkins University and around the globe.
 Remembering Mary Lou Clements-Mann, MD, MPH
On September 2, 2008, the Center for Immunization Research remembered founder Mary Lou Clements-Mann in a private ceremony to observe the 10th anniversary of her passing. Many of Dr. Clements-Mann’s former colleagues were in attendance and shared words of remembrance of the pioneer in vaccine and AIDS research. The group shared in a traditional Texas-style barbeque, a favorite of Dr. Clements-Mann. A special plaque with Dr. Clements-Mann’s photograph was created for the event and is now displayed in a central location at the main facility of the Center for Immunization Research at the Johns Hopkins Bloomberg School of Public Health.
|
|
| | | Respiratory syncytial virus (RSV) is the leading cause of viral lower respiratory tract illness in infants and children worldwide. | 
|
|
|
